Dr Seetal Dodd

Results of the COVID-19 mental health international for the health professionals (COMET-HP) study: depression, suicidal tendencies and conspiracism

K N. Fountoulakis, G N. Karakatsoulis, S Abraham, K Adorjan, H Ahmed, R Alarcón, K Arai, S Auwal, J Bobes, T Bobes-Bascaran, J Bourgin-Duchesnay, C Bredicean, L Bukelskis, A Burkadze, I Cabrera Abud, R Castilla-Puentes, M Cetkovich, H Colon-Rivera, R Corral, C Cortez-Vergara, P Crepin, D de Berardis, S Zamora Delgado, D de Lucena, A de Sousa, R di Stefano, S Dodd, L Elek, A Elissa, B Erdelyi-Hamza, G Erzin, M Etchevers, P Falkai, A Farcas, I Fedotov, V Filatova, N Fountoulakis, I Frankova, F Franza, P Frias, T Galako, C Garay, L Garcia-Álvarez, P García-Portilla, X Gonda, T Gondek, D Morera González, H Gould, P Grandinetti, A Grau, V Groudeva, M Hagin, T Harada, T Hasan, N Azreen Hashim, J Hilbig, S Hossain, R Iakimova, M Ibrahim, F Iftene, Y Ignatenko, M Irarrazaval, Z Ismail, J Ismayilova, A Jacobs, M Jakovljević, N Jakšić, A Javed, H Yilmaz Kafali, S Karia, O Kazakova, D Khalifa, O Khaustova, S Koh, S Kopishinskaia, K Kosenko, S Koupidis, I Kovacs, B Kulig, A Lalljee, J Liewig, A Majid, E Malashonkova, K Malik, N Iqbal Malik, G Mammadzada, B Mandalia, D Marazziti, D Marčinko, S Martinez, E Matiekus, G Mejia, R Memon, X Meza Martínez, D Mickevičiūtė, R Milev, M Mohammed, A Molina-López, P Morozov, N Muhammad

(2023), Social Psychiatry and Psychiatric Epidemiology, C1

Cognition-immune interactions between executive function and working memory, tumour necrosis factor-alpha (TNF-alpha) and soluble TNF receptors (sTNFR1 and sTNFR2) in bipolar disorder

R Zazula, S Dodd, O Dean, M Berk, C Bortolasci, W Verri, H Vargas, S Nunes

(2022), Vol. 23, pp. 67-77, World Journal of Biological Psychiatry, England, C1

Cognitive Profile and Relationship with Quality of Life and Psychosocial Functioning in Mood Disorders

R Zazula, M Mohebbi, S Dodd, O Dean, M Berk, H Vargas, S Nunes

(2022), Vol. 37, pp. 376-389, Archives of Clinical Neuropsychology, United States, C1

Results of the COVID-19 mental health international for the general population (COMET-G) study

K Fountoulakis, G Karakatsoulis, S Abraham, K Adorjan, H Ahmed, R Alarcón, K Arai, S Auwal, M Berk, S Bjedov, J Bobes, T Bobes-Bascaran, J Bourgin-Duchesnay, C Bredicean, L Bukelskis, A Burkadze, I Abud, R Castilla-Puentes, M Cetkovich, H Colon-Rivera, R Corral, C Cortez-Vergara, P Crepin, D De Berardis, S Zamora Delgado, D De Lucena, A De Sousa, R Stefano, S Dodd, L Elek, A Elissa, B Erdelyi-Hamza, G Erzin, M Etchevers, P Falkai, A Farcas, I Fedotov, V Filatova, N Fountoulakis, I Frankova, F Franza, P Frias, T Galako, C Garay, L Garcia-Álvarez, M García-Portilla, X Gonda, T Gondek, D González, H Gould, P Grandinetti, A Grau, V Groudeva, M Hagin, T Harada, T Hasan, N Hashim, J Hilbig, S Hossain, R Iakimova, M Ibrahim, F Iftene, Y Ignatenko, M Irarrazaval, Z Ismail, J Ismayilova, A Jakobs, M Jakovljević, N Jakšić, A Javed, H Kafali, S Karia, O Kazakova, D Khalifa, O Khaustova, S Koh, S Kopishinskaia, K Kosenko, S Koupidis, I Kovacs, B Kulig, A Lalljee, J Liewig, A Majid, E Malashonkova, K Malik, N Malik, G Mammadzada, B Mandalia, D Marazziti, D Marčinko, S Martinez, E Matiekus, G Mejia, R Memon, X Martínez, D Mickevičiūtė, R Milev, M Mohammed, A Molina-López

(2022), Vol. 54, pp. 21-40, European Neuropsychopharmacology, Amsterdam, The Netherlands, C1

Does metabolic syndrome or its component factors alter the course of bipolar disorder? A systematic review

A Giménez-Palomo, S Gomes-da-Costa, S Dodd, I Pachiarotti, N Verdolini, E Vieta, M Berk

(2022), Vol. 132, pp. 142-153, Neuroscience and Biobehavioral Reviews, Amsterdam, The Netherlands, C1

Effect of Glucocorticoid and 11 beta-Hydroxysteroid-Dehydrogenase Type 1 (11 beta-HSD1) in Neurological and Psychiatric Disorders

Seetal Dodd, David Skvarc, Olivia Dean, Anna Anderson, Mark Kotowicz, Michael Berk

(2022), Vol. 25, pp. 387-398, International Journal of Neuropsychopharmacology, Oxford, Eng., C1

Mixed Methods Thematic Analysis of a Randomised Controlled Trial of Adjunctive Mitochondrial Agents for Bipolar Depression

Samantha Russell, Anna Wrobel, Olivia Dean, Michael Berk, Seetal Dodd, Chee Ng, Gin Malhi, Susan Cotton, Jerome Sarris, Alyna Turner

(2022), Vol. 20, pp. 300-310, Clinical psychopharmacology and neuroscience, Seoul, Korea (South), C1

The effect of different degrees of lockdown and self-identified gender on anxiety, depression and suicidality during the COVID-19 pandemic: Data from the international COMET-G study.

K Fountoulakis, G Karakatsoulis, S Abraham, K Adorjan, H Ahmed, R Alarcón, K Arai, S Auwal, M Berk, S Bjedov, J Bobes, T Bobes-Bascaran, J Bourgin-Duchesnay, C Bredicean, L Bukelskis, A Burkadze, I Abud, R Castilla-Puentes, M Cetkovich, H Colon-Rivera, R Corral, C Cortez-Vergara, P Crepin, D De Berardis, S Delgado, D De Lucena, A De Sousa, R Stefano, S Dodd, L Elek, A Elissa, B Erdelyi-Hamza, G Erzin, M Etchevers, P Falkai, A Farcas, I Fedotov, V Filatova, N Fountoulakis, I Frankova, F Franza, P Frias, T Galako, C Garay, L Garcia-Álvarez, M García-Portilla, X Gonda, T Gondek, D González, H Gould, P Grandinetti, A Grau, V Groudeva, M Hagin, T Harada, T Hasan, N Hashim, J Hilbig, S Hossain, R Iakimova, M Ibrahim, F Iftene, Y Ignatenko, M Irarrazaval, Z Ismail, J Ismayilova, A Jacobs, M Jakovljević, N Jakšić, A Javed, H Kafali, S Karia, O Kazakova, D Khalifa, O Khaustova, S Koh, S Kopishinskaia, K Kosenko, S Koupidis, I Kovacs, B Kulig, A Lalljee, J Liewig, A Majid, E Malashonkova, K Malik, N Malik, G Mammadzada, B Mandalia, D Marazziti, D Marčinko, S Martinez, E Matiekus, G Mejia, R Memon, X Martínez, D Mickevičiūtė, R Milev, M Mohammed, A Molina-López

(2022), Vol. 315, Psychiatry Research, Ireland, C1

Psilocybin in Neuropsychiatry: A review of its pharmacology, safety and efficacy

S Dodd, T Norman, H Eyre, S Stahl, A Phillips, A Carvalho, M Berk

(2022), CNS Spectrums, United States, C1

Association between polarity of first episode and solar insolation in bipolar I disorder

M Bauer, T Glenn, E Achtyes, M Alda, E Agaoglu, K Altınbaş, O Andreassen, E Angelopoulos, R Ardau, M Aydin, Y Ayhan, C Baethge, R Bauer, B Baune, C Balaban, C Becerra-Palars, A Behere, P Behere, H Belete, T Belete, G Belizario, F Bellivier, R Belmaker, F Benedetti, M Berk, Y Bersudsky, Ş Bicakci, H Birabwa-Oketcho, T Bjella, C Brady, J Cabrera, M Cappucciati, A Paredes Castro, W Chen, E Cheung, S Chiesa, M Crowe, A Cuomo, S Dallaspezia, M Del Zompo, P Desai, S Dodd, B Etain, A Fagiolini, F Fellendorf, E Ferensztajn-Rochowiak, J Fiedorowicz, K Fountoulakis, M Frye, P Geoffroy, A Gonzalez-Pinto, J Gottlieb, P Grof, B Haarman, H Harima, M Hasse-Sousa, C Henry, L Høffding, J Houenou, M Imbesi, E Isometsä, M Ivkovic, S Janno, S Johnsen, F Kapczinski, G Karakatsoulis, M Kardell, L Kessing, S Kim, B König, T Kot, M Koval, M Kunz, B Lafer, M Landén, E Larsen, M Lenger, U Lewitzka, R Licht, C Lopez-Jaramillo, A MacKenzie, H Madsen, S Madsen, J Mahadevan, A Mahardika, M Manchia, W Marsh, M Martinez-Cengotitabengoa, K Martiny, Y Mashima, D McLoughlin, Y Meesters, I Melle, F Meza-Urzúa, Y Mok, S Monteith, M Moorthy, G Morken, E Mosca, A Mozzhegorov

(2022), Vol. 160, pp. 1-10, Journal of Psychosomatic Research, Amsterdam, The Netherlands, C1

The role of metformin as a treatment for neuropsychiatric illness

S Dodd, L Sominsky, D Siskind, C Bortolasci, A Carvalho, M Maes, A Walker, K Walder, A Yung, L Williams, H Myles, T Watson, M Berk

(2022), Vol. 64, pp. 32-43, European Neuropsychopharmacology, Netherlands, C1

Trace amine-associated receptor 1 (TAAR1): a new drug target for psychiatry?

S Dodd, A Carvalho, B Puri, M Maes, C Bortolasci, G Morris, M Berk

(2021), Vol. 120, pp. 537-541, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

The effect of concomitant benzodiazepine use on neurocognition in stable, long-term patients with bipolar disorder

Y Cañada, A Sabater, P Sierra, V Balanzá-Martínez, M Berk, S Dodd, P Navalón, L Livianos, A García-Blanco

(2021), Vol. 55, pp. 1005-1016, Australian and New Zealand Journal of Psychiatry, England, C1

A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?

S Dodd, M Bauer, A Carvalho, H Eyre, M Fava, S Kasper, S Kennedy, J Khoo, C Lopez Jaramillo, G Malhi, R McIntyre, P Mitchell, A Castro, A Ratheesh, E Severus, T Suppes, M Trivedi, M Thase, L Yatham, A Young, M Berk

(2021), Vol. 22, pp. 483-494, World Journal of Biological Psychiatry, England, C1

Adjunctive Garcinia mangostana Linn. (Mangosteen) Pericarp for Schizophrenia: A 24-Week Double-blind, Randomized, Placebo Controlled Efficacy Trial: Péricarpe d'appoint Garcinia mangostana Linn (mangoustan) pour la schizophrénie : un essai d'efficacité de 24 semaines, à double insu, randomisé et contrôlé par placebo

A Turner, A Baker, O Dean, A Walker, S Dodd, S Cotton, J Scott, B Kavanagh, M Ashton, E Brown, J McGrath, M Berk

(2021), Vol. 66, pp. 354-366, Canadian Journal of Psychiatry, United States, C1

Effects of aspirin on the long-term management of depression in older people: a double-blind randomised placebo-controlled trial

M Berk, B Agustini, R Woods, M Nelson, R Shah, C Reid, E Storey, S Fitzgerald, J Lockery, R Wolfe, M Mohebbi, S Dodd, A Murray, N Stocks, P Fitzgerald, C Mazza, J McNeil

(2021), Vol. 26, pp. 5161-5170, Molecular Psychiatry, England, C1

Age as a predictor of quit attempts and quit success in smoking cessation: findings from the International Tobacco Control Four-Country survey (2002-14)

L Arancini, R Borland, M Le Grande, M Mohebbi, S Dodd, O Dean, M Berk, A McNeill, G Fong, K Cummings

(2021), Vol. 116, pp. 2509-2520, Addiction, England, C1

Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation

R McIntyre, J Rosenblat, C Nemeroff, G Sanacora, J Murrough, M Berk, E Brietzke, S Dodd, P Gorwood, R Ho, D Iosifescu, C Jaramillo, S Kasper, K Kratiuk, J Lee, Y Lee, L Lui, R Mansur, G Papakostas, M Subramaniapillai, M Thase, E Vieta, A Young, C Zarate, S Stahl

(2021), Vol. 178, pp. 383-399, American Journal of Psychiatry, Washington, D.C., C1

Risk of cancer in bipolar disorder and the potential role of lithium: International collaborative systematic review and meta-analyses

G Anmella, G Fico, M Lotfaliany, D Hidalgo-Mazzei, Ó Soto-Angona, A Giménez-Palomo, S Amoretti, A Murru, J Radua, A Solanes, I Pacchiarotti, N Verdolini, S Cowdery, S Dodd, L Williams, M Mohebbi, A Carvalho, L Kessing, E Vieta, M Berk

(2021), Vol. 126, pp. 529-541, Neuroscience and Biobehavioral Reviews, United States, C1

The Effect of Adjunctive Mangosteen Pericarp on Cognition in People With Schizophrenia: Secondary Analysis of a Randomized Controlled Trial

W Marx, D Skvarc, M Mohebbi, A Walker, A Meehan, A Turner, A Baker, S Dodd, S Cotton, J Scott, B Kavanagh, M Ashton, E Brown, J McGrath, M Berk, O Dean

(2021), Vol. 12, Frontiers in Psychiatry, Switzerland, C1

Statins: Neurobiological underpinnings and mechanisms in mood disorders

A Walker, Y Kim, I Borissiouk, R Rehder, S Dodd, G Morris, A Nierenberg, M Maes, B Fernandes, O Dean, L Williams, H Eyre, S Kim, S Zoungas, A Carvalho, M Berk

(2021), Vol. 128, pp. 693-708, Neuroscience and Biobehavioral Reviews, Amsterdam, The Netherlands, C1

The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment

A Giménez-Palomo, S Dodd, G Anmella, A Carvalho, G Scaini, J Quevedo, I Pacchiarotti, E Vieta, M Berk

(2021), Vol. 12, Frontiers in Psychiatry, Switzerland, C1

Variations in seasonal solar insolation are associated with a history of suicide attempts in bipolar I disorder

M Bauer, T Glenn, E Achtyes, M Alda, E Agaoglu, K Altınbaş, O Andreassen, E Angelopoulos, R Ardau, E Vares, M Aydin, Y Ayhan, C Baethge, R Bauer, B Baune, C Balaban, C Becerra-Palars, A Behere, P Behere, H Belete, T Belete, G Belizario, F Bellivier, R Belmaker, F Benedetti, M Berk, Y Bersudsky, Ş Bicakci, H Birabwa-Oketcho, T Bjella, C Brady, J Cabrera, M Cappucciati, A Castro, W Chen, E Cheung, S Chiesa, M Crowe, A Cuomo, S Dallaspezia, M Del Zompo, P Desai, S Dodd, M Donix, B Etain, A Fagiolini, F Fellendorf, E Ferensztajn-Rochowiak, J Fiedorowicz, K Fountoulakis, M Frye, P Geoffroy, A Gonzalez-Pinto, J Gottlieb, P Grof, B Haarman, H Harima, M Hasse-Sousa, C Henry, L Høffding, J Houenou, M Imbesi, E Isometsä, M Ivkovic, S Janno, S Johnsen, F Kapczinski, G Karakatsoulis, M Kardell, L Kessing, S Kim, B König, T Kot, M Koval, M Kunz, B Lafer, M Landén, E Larsen, M Lenger, U Lewitzka, R Licht, C Lopez-Jaramillo, A MacKenzie, H Madsen, S Madsen, J Mahadevan, A Mahardika, M Manchia, W Marsh, M Martinez-Cengotitabengoa, K Martiny, Y Mashima, D McLoughlin, Y Meesters, I Melle, F Meza-Urzúa, M Ming, S Monteith, M Moorthy, G Morken

(2021), Vol. 9, International Journal of Bipolar Disorders, Germany, C1

A placebo-controlled, randomised pilot trial of N-acetylcysteine or placebo for cessation of tobacco smoking

L Arancini, M Mohebbi, M Berk, O Dean, C Bortolasci, B Spolding, R Zazula, S Dodd

(2021), Vol. 53, pp. 120-126, European Neuropsychopharmacology, Amsterdam, The Netherlands, C1

Diet quality, dietary inflammatory index and body mass index as predictors of response to adjunctive N-acetylcysteine and mitochondrial agents in adults with bipolar disorder: a sub-study of a randomised placebo-controlled trial

M Ashton, O Dean, W Marx, M Mohebbi, M Berk, G Malhi, C Ng, S Cotton, S Dodd, J Sarris, M Hopwood, K Faye-Chauhan, Y Kim, S Dash, F Jacka, N Shivappa, J Hebert, A Turner

(2020), Vol. 54, pp. 159-172, Australian and New Zealand journal of psychiatry, London, Eng., C1

Physical activity as a predictor of clinical trial outcomes in bipolar depression: a subanalysis of a mitochondrial-enhancing nutraceutical randomized controlled trial

M Ashton, M Mohebbi, A Turner, W Marx, M Berk, G Malhi, C Ng, S Cotton, S Dodd, J Sarris, M Hopwood, B Stubbs, O Dean

(2020), Vol. 65, pp. 306-318, Canadian journal of psychiatry, London, Eng., C1

Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): A randomised clinical trial of rosuvastatin and aspirin

M Berk, M Mohebbi, O Dean, S Cotton, A Chanen, S Dodd, A Ratheesh, G Amminger, M Phelan, A Weller, A MacKinnon, F Giorlando, S Baird, L Incerti, R Brodie, N Ferguson, S Rice, M Schäfer, E Mullen, S Hetrick, M Kerr, S Harrigan, A Quinn, C Mazza, P McGorry, C Davey

(2020), Vol. 18, BMC Medicine, England, C1

Effect of aspirin vs placebo on the prevention of depression in older people: a randomized clinical trial

M Berk, R Woods, M Nelson, R Shah, C Reid, E Storey, S Fitzgerald, J Lockery, R Wolfe, M Mohebbi, S Dodd, A Murray, N Stocks, P Fitzgerald, C Mazza, B Agustini, J McNeil

(2020), Vol. 77, pp. 1012-1020, JAMA psychiatry, Chicago, Ill., C1

Interleukin-6 and total antioxidant capacity levels following N-acetylcysteine and a combination nutraceutical intervention in a randomised controlled trial for bipolar disorder

C Bortolasci, C Voigt, A Turner, M Mohebbi, L Gray, S Dodd, K Walder, M Berk, S Cotton, G Malhi, C Ng, N Dowling, J Sarris, O Dean

(2020), Vol. 32, pp. 313-320, Acta Neuropsychiatrica, England, C1

Exploring A-Acetylcysteine in Psychiatry

A Gimenez-Palomo, S Dodd, O Dean, C Bortolasci, M Berk

(2020), Vol. 37, pp. 48-51, Psychiatric Times, Santa Ana, Calif., C1-1

A randomized controlled trial of MoodSwings 2.0: An internet-based self-management program for bipolar disorder

E Gliddon, V Cosgrove, L Berk, S Lauder, M Mohebbi, D Grimm, S Dodd, C Coulson, K Raju, T Suppes, M Berk

(2019), Vol. 21, pp. 28-39, Bipolar Disorders, London, Eng., C1

Does N-acetylcysteine improve behaviour in children with autism?: A mixed-methods analysis of the effects of N-acetylcysteine

O Dean, K Gray, S Dodd, K Villagonzalo, E Brown, B Tonge, M Berk, L Byrne

(2019), Vol. 44, pp. 474-480, Journal of Intellectual and Developmental Disability, C1

Efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study protocol for a proof-of-concept trial

Melanie Ashton, Michael Berk, Chee Ng, Malcolm Hopwood, Seetal Dodd, Alyna Turner, Ellie Brown, Felice Jacka, Susan Cotton, Jon-Paul Khoo, Mary Chatterton, Bianca Kavanagh, Sarah Nadjidai, Samantha Lo Monaco, Brian Harvey, Jerome Sarris, Gin Malhi, Nathan Dowling, Olivia Dean

(2019), Vol. 41, pp. 245-253, Brazilian journal of psychiatry, Sao Paulo, Brazil, C1

A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: Mitochondrial agents, N-acetylcysteine, and placebo

M Berk, A Turner, G Malhi, C Ng, S Cotton, S Dodd, Y Samuni, M Tanious, C McAulay, N Dowling, J Sarris, L Owen, A Waterdrinker, D Smith, O Dean

(2019), Vol. 17, BMC Medicine, England, C1

Putative neuroprotective pharmacotherapies to target the staged progression of mental illness

O Robertson, N Coronado, R Sethi, M Berk, S Dodd

(2019), Vol. 13, pp. 1032-1049, Early Intervention in Psychiatry, Australia, C1

Association between solar insolation and a history of suicide attempts in bipolar I disorder

M Bauer, T Glenn, M Alda, O Andreassen, E Angelopoulos, R Ardau, Y Ayhan, C Baethge, R Bauer, B Baune, C Becerra-Palars, F Bellivier, R Belmaker, M Berk, Y Bersudsky, Ş Bicakci, H Birabwa-Oketcho, T Bjella, J Cabrera, E Wo Cheung, M Del Zompo, S Dodd, M Donix, B Etain, A Fagiolini, K Fountoulakis, M Frye, A Gonzalez-Pinto, J Gottlieb, P Grof, H Harima, C Henry, E Isometsä, S Janno, F Kapczinski, M Kardell, S Khaldi, S Kliwicki, B König, T Kot, R Krogh, M Kunz, B Lafer, M Landén, E Larsen, U Lewitzka, R Licht, C Lopez-Jaramillo, G MacQueen, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, F Meza-Urzúa, M Ming, S Monteith, G Morken, E Mosca, A Mozzhegorov, R Munoz, S Mythri, F Nacef, R Nadella, F Nery, R Nielsen, C O'Donovan, A Omrani, Y Osher, H Sørensen, U Ouali, Y Ruiz, M Pilhatsch, M Pinna, F da Ponte, D Quiroz, R Ramesar, N Rasgon, M Reddy, A Reif, P Ritter, J Rybakowski, K Sagduyu, B Raghuraman, Â Scippa, E Severus, C Simhandl, P Stackhouse, D Stein, S Strejilevich, M Subramaniam, A Sulaiman, K Suominen, H Tagata, Y Tatebayashi, L Tondo, C Torrent, A Vaaler, E Vares, J Veeh, E Vieta

(2019), Vol. 113, pp. 1-9, Journal of Psychiatric Research, England, C1

The therapeutic potential of mangosteen pericarp as an adjunctive therapy for bipolar disorder and schizophrenia

M Ashton, O Dean, A Walker, C Bortolasci, C Ng, M Hopwood, B Harvey, M Möller, J McGrath, W Marx, A Turner, S Dodd, J Scott, J Khoo, K Walder, J Sarris, M Berk

(2019), Vol. 10, Frontiers in Psychiatry, Switzerland, C1

Protocol and rationale: a 24-week double-blind, randomized, placebo controlled trial of the efficacy of adjunctive garcinia mangostanaLinn. (mangosteen) pericarp for schizophrenia

Alyna Turner, John McGrath, Olivia Dean, Seetal Dodd, Andrea Baker, Susan Cotton, James Scott, Bianca Kavanagh, Melanie Ashton, Adam Walker, Ellie Brown, Michael Berk

(2019), Vol. 17, pp. 297-307, Clinical psychopharmacology and neuroscience, Seoul, South Korea, C1

N-acetylcysteine for cessation of tobacco smoking: Rationale and study protocol for a randomised controlled trial

L Arancini, C Bortolasci, S Dodd, O Dean, M Berk

(2019), Vol. 20, Trials, England, C1

Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders

R Sethi, N Gómez-Coronado, A Walker, O Robertson, B Agustini, M Berk, S Dodd

(2019), Vol. 10, Frontiers in Psychiatry, Switzerland, C1

ENACT: A protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis

S Cotton, M Berk, A Watson, S Wood, K Allott, C Bartholomeusz, C Bortolasci, K Walder, B O'Donoghue, O Dean, A Chanen, G Amminger, P McGorry, A Burnside, J Uren, A Ratheesh, S Dodd

(2019), Vol. 20, Trials, England, C1

Incidence and characteristics of the nocebo response from meta-analyses of the placebo arms of clinical trials of olanzapine for bipolar disorder

S Dodd, A Walker, A Brnabic, N Hong, A Burns, M Berk

(2019), Vol. 21, pp. 142-150, Bipolar Disorders, Denmark, C1

Youth Depression Alleviation-Augmentation with an anti-inflammatory agent (YoDA-A): protocol and rationale for a placebo-controlled randomized trial of rosuvastatin and aspirin

A Quinn, O Dean, C Davey, M Kerr, S Harrigan, S Cotton, A Chanen, S Dodd, A Ratheesh, G Amminger, M Phelan, A Williams, A Mackinnon, F Giorlando, S Baird, S Rice, M O'Shea, M Schäfer, E Mullen, S Hetrick, P McGorry, M Berk

(2018), Vol. 12, pp. 45-54, Early Intervention in Psychiatry, Australia, C1

Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement

S Dodd, P Mitchell, M Bauer, L Yatham, A Young, S Kennedy, L Williams, T Suppes, C Lopez Jaramillo, M Trivedi, M Fava, A Rush, R McIntyre, M Thase, R Lam, E Severus, S Kasper, M Berk

(2018), Vol. 19, pp. 330-348, World Journal of Biological Psychiatry, England, C1

Post-operative cognitive dysfunction: an exploration of the inflammatory hypothesis and novel therapies

D Skvarc, M Berk, L Byrne, O Dean, S Dodd, M Lewis, A Marriott, E Moore, G Morris, R Page, L Gray

(2018), Vol. 84, pp. 116-133, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

Current and Emerging Pharmacotherapies for Cessation of Tobacco Smoking

N Gómez-Coronado, A Walker, M Berk, S Dodd

(2018), Vol. 38, pp. 235-258, Pharmacotherapy, United States, C1

Mechanisms underpinning the polypharmacy effects of medications in psychiatry

C Bortolasci, B Spolding, E Callaly, S Martin, B Panizzutti, S Kidnapillai, T Connor, K Hasebe, M Mohebbi, O Dean, S McGee, S Dodd, L Gray, M Berk, K Walder

(2018), Vol. 21, pp. 582-591, International Journal of Neuropsychopharmacology, England, C1

Patient centric measures for a patient centric era: Agreement and convergent between ratings on The Patient Global Impression of Improvement (PGI-I) scale and the Clinical Global Impressions - Improvement (CGI-S) scale in bipolar and major depressive disorder

M Mohebbi, S Dodd, O Dean, M Berk

(2018), Vol. 53, pp. 17-22, European Psychiatry, England, C1

Mediator effects of parameters of inflammation and neurogenesis from a N-acetyl cysteine clinical-trial for bipolar depression

B Panizzutti, C Bortolasci, K Hasebe, S Kidnapillai, L Gray, K Walder, M Berk, M Mohebbi, S Dodd, C Gama, P Magalhães, S Cotton, F Kapczinski, A Bush, G Malhi, O Dean

(2018), Vol. 30, pp. 334-341, Acta Neuropsychiatrica, England, C1

A review of the neurobiological underpinning of comorbid substance use and mood disorders

N Gómez-Coronado, R Sethi, C Bortolasci, L Arancini, M Berk, S Dodd

(2018), Vol. 241, pp. 388-401, Journal of Affective Disorders, Netherlands, C1

Internet use by older adults with bipolar disorder: international survey results

R Bauer, T Glenn, S Strejilevich, J Conell, M Alda, R Ardau, B Baune, M Berk, Y Bersudsky, A Bilderbeck, A Bocchetta, A Castro, E Cheung, C Chillotti, S Choppin, A Cuomo, M Del Zompo, R Dias, S Dodd, A Duffy, B Etain, A Fagiolini, M Fernández Hernandez, J Garnham, J Geddes, J Gildebro, M Gitlin, A Gonzalez-Pinto, G Goodwin, P Grof, H Harima, S Hassel, C Henry, D Hidalgo-Mazzei, A Lund, V Kapur, G Kunigiri, B Lafer, E Larsen, U Lewitzka, R Licht, B Misiak, P Piotrowski, Â Miranda-Scippa, S Monteith, R Munoz, T Nakanotani, R Nielsen, C O’Donovan, Y Okamura, Y Osher, A Reif, P Ritter, J Rybakowski, K Sagduyu, B Sawchuk, E Schwartz, C Slaney, A Sulaiman, K Suominen, A Suwalska, P Tam, Y Tatebayashi, L Tondo, J Veeh, E Vieta, M Vinberg, B Viswanath, M Zetin, P Whybrow, M Bauer

(2018), Vol. 6, International Journal of Bipolar Disorders, Germany, C1

Toward Precision Psychiatry in Bipolar Disorder: Staging 2.0

E Salagre, S Dodd, A Aedo, A Rosa, S Amoretti, J Pinzon, M Reinares, M Berk, F Kapczinski, E Vieta, I Grande

(2018), Vol. 9, Frontiers in Psychiatry, Switzerland, C1

A randomised, double blind, placebo-controlled trial of a fixed dose of N -acetyl cysteine in children with autistic disorder

O Dean, K Gray, K Villagonzalo, S Dodd, M Mohebbi, T Vick, B Tonge, M Berk

(2017), Vol. 51, pp. 241-249, Australian and New Zealand Journal of Psychiatry, England, C1

Why so GLUMM? Detecting depression clusters through graphing lifestyle-environs using machine-learning methods (GLUMM)

J Dipnall, J Pasco, M Berk, L Williams, S Dodd, F Jacka, D Meyer

(2017), Vol. 39, pp. 40-50, European Psychiatry, England, C1

Cognitive effects of adjunctive N-acetyl cysteine in psychosis

M Rapado-Castro, S Dodd, A Bush, G Malhi, D Skvarc, Z On, M Berk, O Dean

(2017), Vol. 47, pp. 866-876, Psychological Medicine, England, C1

A review of the theoretical and biological understanding of the nocebo and placebo phenomena

S Dodd, O Dean, J Vian, M Berk

(2017), Vol. 39, pp. 469-476, Clinical therapeutics, Amsterdam, The Netherlands, C1

The placebo and nocebo phenomena: their clinical management and impact on treatment outcomes

V Chavarria, J Vian, C Pereira, J Data-Franco, B Fernandes, M Berk, S Dodd

(2017), Vol. 39, pp. 477-486, Clinical therapeutics, New York, N.Y., C1

Progressing MoodSwings. The upgrade and evaluation of MoodSwings 2.0: an online intervention for bipolar disorder

S Lauder, V Cosgrove, E Gliddon, D Grimm, S Dodd, L Berk, D Castle, T Suppes, M Berk

(2017), Vol. 56, pp. 18-24, Contemporary clinical trials, Amsterdam, The Netherlands, C1

Adjunctive N-acetylcysteine in depression: Exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factor

K Hasebe, L Gray, C Bortolasci, B Panizzutti, M Mohebbi, S Kidnapillai, B Spolding, K Walder, M Berk, G Malhi, S Dodd, O Dean

(2017), Vol. 29, pp. 337-346, Acta Neuropsychiatrica, England, C1

Homocysteine as a peripheral biomarker in bipolar disorder: A meta-analysis

E Salagre, A Vizuete, M Leite, D Brownstein, A McGuinness, F Jacka, S Dodd, B Stubbs, C Köhler, E Vieta, A Carvalho, M Berk, B Fernandes

(2017), Vol. 43, pp. 81-91, European Psychiatry, England, C1

Impact of irritability: a 2-year observational study of outpatients with bipolar I or schizoaffective disorder

L Berk, K Hallam, K Venugopal, A Lewis, D Austin, J Kulkarni, S Dodd, A de Castella, P Fitzgerald, M Berk

(2017), Vol. 19, pp. 184-197, Bipolar disorders, Hoboken, N.J., C1

International multi-site survey on the use of online support groups in bipolar disorder

R Bauer, J Conell, T Glenn, M Alda, R Ardau, B Baune, M Berk, Y Bersudsky, A Bilderbeck, A Bocchetta, L Bossini, A Castro, E Cheung, C Chillotti, S Choppin, M Zompo, R Dias, S Dodd, A Duffy, B Etain

(2017), Vol. 71, pp. 473-476, Nordic Journal of Psychiatry, Abingdon, Eng, C1

Indices of insulin resistance and glucotoxicity are not associated with bipolar disorder or major depressive disorder, but are differently associated with inflammatory, oxidative and nitrosative biomarkers

K Landucci Bonifácio, D Sabbatini Barbosa, E Gastaldello Moreira, C de Farias, L Higachi, A Camargo, J Favaro Soares, H Odebrecht Vargas, S Nunes, M Berk, S Dodd, M Maes

(2017), Vol. 222, pp. 185-194, Journal of Affective Disorders, Netherlands, C1

Solar insolation in springtime influences age of onset of bipolar I disorder

M Bauer, T Glenn, M Alda, M Aleksandrovich, O Andreassen, E Angelopoulos, R Ardau, Y Ayhan, C Baethge, S Bharathram, R Bauer, B Baune, C Becerra-Palars, F Bellivier, R Belmaker, M Berk, Y Bersudsky, Bicakci, H Birabwa-Oketcho, T Bjella, L Bossini, J Cabrera, E Cheung, M Del Zompo, S Dodd, M Donix, B Etain, A Fagiolini, K Fountoulakis, M Frye, A Gonzalez-Pinto, J Gottlieb, P Grof, H Harima, C Henry, E Isometsä, S Janno, F Kapczinski, M Kardell, S Khaldi, S Kliwicki, B König, T Kot, R Krogh, M Kunz, B Lafer, M Landén, E Larsen, U Lewitzka, R Licht, C Lopez-Jaramillo, G MacQueen, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, F Meza-Urzúa, M Yee Ming, S Monteith, G Morken, E Mosca, R Munoz, S Mythri, F Nacef, R Nadella, F Nery, R Nielsen, C O'Donovan, A Omrani, Y Osher, H Østermark Sørensen, U Ouali, Y Pica Ruiz, M Pilhatsch, M Pinna, F da Ponte, D Quiroz, R Ramesar, N Rasgon, M Reddy, A Reif, P Ritter, J Rybakowski, K Sagduyu, M Scippa, E Severus, C Simhandl, D Stein, S Strejilevich, M Subramaniam, A Sulaiman, K Suominen, H Tagata, Y Tatebayashi, L Tondo, C Torrent, A Vaaler, J Veeh, E Vieta, B Viswanath

(2017), Vol. 136, pp. 571-582, Acta Psychiatrica Scandinavica, United States, C1

Online ethics: where will the interface of mental health and the internet lead us?

V Cosgrove, E Gliddon, L Berk, D Grimm, S Lauder, S Dodd, M Berk, T Suppes

(2017), Vol. 5, International Journal of Bipolar Disorders, Germany, C1

Getting RID of the blues: Formulating a Risk Index for Depression (RID) using structural equation modeling

J Dipnall, J Pasco, M Berk, L Williams, S Dodd, F Jacka, D Meyer

(2017), Vol. 51, pp. 1121-1133, Australian and New Zealand Journal of Psychiatry, England, C1

Staging in bipolar disorder: from theoretical framework to clinical utility

M Berk, R Post, A Ratheesh, E Gliddon, A Singh, E Vieta, A Carvalho, M Ashton, L Berk, S Cotton, P McGorry, B Fernandes, L Yatham, S Dodd

(2017), Vol. 16, pp. 236-244, World psychiatry, Chichester, Eng., C1

C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: Meta-analysis and implications

B Fernandes, J Steiner, H Bernstein, S Dodd, J Pasco, O Dean, P Nardin, C Gonçalves, M Berk

(2016), Vol. 21, pp. 554-564, Molecular Psychiatry, England, C1

Citalopram and sertraline exposure compromises embryonic bone development

D Fraher, J Hodge, F Collier, J McMillan, R Kennedy, M Ellis, G Nicholson, K Walder, S Dodd, M Berk, J Pasco, L Williams, Y Gibert

(2016), Vol. 21, pp. 656-664, Molecular Psychiatry, England, C1

Fusing data mining, machine learning and traditional statistics to detect biomarkers associated with depression

J Dipnall, J Pasco, M Berk, L Williams, S Dodd, F Jacka, D Meyer

(2016), Vol. 11, PLoS ONE, United States, C1

Leptin in bipolar disorder: A systematic review and meta-analysis

B Fernandes, S Dash, F Jacka, S Dodd, A Carvalho, C Köhler, J Steiner, M da Graça Cantarelli, P Nardin, C Gonçalves, M Berk

(2016), Vol. 35, pp. 1-7, European Psychiatry, England, C1

A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis

J Davis, H Eyre, F Jacka, S Dodd, O Dean, S McEwen, M Debnath, J McGrath, M Maes, P Amminger, P McGorry, C Pantelis, M Berk

(2016), Vol. 65, pp. 185-194, Neuroscience and Biobehavioral Reviews, United States, C1

N-acetylcysteine in depressive symptoms and functionality: A systematic review and meta-analysis

B Fernandes, O Dean, S Dodd, G Malhi, M Berk

(2016), Vol. 77, pp. e457-e466, Journal of Clinical Psychiatry, United States, C1

Statins for the treatment of depression: a meta-analysis of randomized, double-blind, placebo-controlled trials

E Salagre, B Fernandes, S Dodd, D Brownstein, M Berk

(2016), Vol. 200, pp. 235-242, Journal of affective disorders, Amsterdam, The Netherlands, C1

Internet use by patients with bipolar disorder: Results from an international multisite survey

R Bauer, J Conell, T Glenn, M Alda, R Ardau, B Baune, M Berk, Y Bersudsky, A Bilderbeck, A Bocchetta, L Bossini, A Castro, E Cheung, C Chillotti, S Choppin, M Del Zompo, R Dias, S Dodd, A Duffy, B Etain, A Fagiolini, M Hernandez, J Garnham, J Geddes, J Gildebro, A Gonzalez-Pinto, G Goodwin, P Grof, H Harima, S Hassel, C Henry, D Hidalgo-Mazzei, V Kapur, G Kunigiri, B Lafer, E Larsen, U Lewitzka, R Licht, A Lund, B Misiak, S Monteith, R Munoz, T Nakanotani, R Nielsen, C O'Donovan, Y Okamura, Y Osher, P Piotrowski, A Reif, P Ritter, J Rybakowski, K Sagduyu, B Sawchuk, E Schwartz, Â Scippa, C Slaney, A Sulaiman, K Suominen, A Suwalska, P Tam, Y Tatebayashi, L Tondo, E Vieta, M Vinberg, B Viswanath, J Volkert, M Zetin, P Whybrow, M Bauer

(2016), Vol. 242, pp. 388-394, Psychiatry Research, Ireland, C1

Online information seeking by patients with bipolar disorder: results from an international multisite survey

J Conell, R Bauer, T Glenn, M Alda, R Ardau, B Baune, M Berk, Y Bersudsky, A Bilderbeck, A Bocchetta, L Bossini, A Paredes Castro, E Cheung, C Chillotti, S Choppin, M Del Zompo, R Dias, S Dodd, A Duffy, B Etain, A Fagiolini, J Garnham, J Geddes, J Gildebro, A Gonzalez-Pinto, G Goodwin, P Grof, H Harima, S Hassel, C Henry, D Hidalgo-Mazzei, V Kapur, G Kunigiri, B Lafer, C Lam, E Larsen, U Lewitzka, R Licht, A Lund, B Misiak, P Piotrowski, S Monteith, R Munoz, T Nakanotani, R Nielsen, C O’Donovan, Y Okamura, Y Osher, A Reif, P Ritter, J Rybakowski, K Sagduyu, B Sawchuk, E Schwartz, Â Scippa, C Slaney, A Sulaiman, K Suominen, A Suwalska, P Tam, Y Tatebayashi, L Tondo, E Vieta, M Vinberg, B Viswanath, J Volkert, M Zetin, I Zorrilla, P Whybrow, M Bauer

(2016), Vol. 4, International Journal of Bipolar Disorders, Germany, C1

C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis

B Fernandes, J Steiner, M Molendijk, S Dodd, P Nardin, C Gonçalves, F Jacka, C Köhler, C Karmakar, A Carvalho, M Berk

(2016), Vol. 3, pp. 1147-1156, The Lancet Psychiatry, England, C1

Into the bowels of depression: Unravelling medical symptoms associated with depression by applying machine-learning techniques to a community based population sample

J Dipnall, J Pasco, M Berk, L Williams, S Dodd, F Jacka, D Meyer

(2016), Vol. 11, PLoS ONE, United States, C1

Towards stage specific treatments: Effects of duration of illness on therapeutic response to adjunctive treatment with N-acetyl cysteine in schizophrenia.

M Rapado-Castro, M Berk, K Venugopal, A Bush, S Dodd, O Dean

(2015), Vol. 57, pp. 69-75, Progress in Neuro-Psychopharmacology and Biological Psychiatry, Amsterdam, The Netherlands, C1

A randomized head to head trial of MoodSwings.net.au: an internet based self-help program for bipolar disorder

S Lauder, A Chester, D Castle, S Dodd, E Gliddon, L Berk, J Chamberlain, B Klein, M Gilbert, D Austin, M Berk

(2015), Vol. 171, pp. 13-21, Journal of affective disorders, Amsterdam, The Netherlands, C1

Restless leg syndrome associated with atypical antipsychotics : current status, pathophysiology, and clinical implications

S Aggarwal, S Dodd, M Berk

(2015), Vol. 10, pp. 98-105, Current drug safety, San Francisco, Calif., C1-1

Influence of birth cohort on age of onset cluster analysis in bipolar I disorder

M Bauer, T Glenn, M Alda, O Andreassen, E Angelopoulos, R Ardau, C Baethge, R Bauer, F Bellivier, R Belmaker, M Berk, T Bjella, L Bossini, Y Bersudsky, E Cheung, J Conell, M Del Zompo, S Dodd, B Etain, A Fagiolini, M Frye, K Fountoulakis, J Garneau-Fournier, A Gonzalez-Pinto, H Harima, S Hassel, C Henry, A Iacovides, E Isometsä, F Kapczinski, S Kliwicki, B König, R Krogh, M Kunz, B Lafer, E Larsen, U Lewitzka, C Lopez-Jaramillo, G MacQueen, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, S Monteith, G Morken, R Munoz, F Nery, C O'Donovan, Y Osher, A Pfennig, D Quiroz, R Ramesar, N Rasgon, A Reif, P Ritter, J Rybakowski, K Sagduyu, A Scippa, E Severus, C Simhandl, D Stein, S Strejilevich, A Hatim Sulaiman, K Suominen, H Tagata, Y Tatebayashi, C Torrent, E Vieta, B Viswanath, M Wanchoo, M Zetin, P Whybrow

(2015), Vol. 30, pp. 99-105, European psychiatry, Amsterdam, Netherlands, C1

N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study

E Prado, M Maes, L Piccoli, M Baracat, D Barbosa, O Franco, S Dodd, M Berk, S Vargas Nunes

(2015), Redox report, Edinburgh, Scotland, C1

Factors influencing insulin resistance in relation to atherogenicity in mood disorders, the metabolic syndrome and tobacco use disorder

C Bortolasci, H Vargas, S Vargas Nunes, L de Melo, M de Castro, E Moreira, S Dodd, D Barbosa, M Berk, M Maes

(2015), Vol. 179, pp. 148-155, Journal of affective disorders, Amsterdam, The Netherlands, C1

Influence of light exposure during early life on the age of onset of bipolar disorder

M Bauer, T Glenn, M Alda, O Andreassen, E Angelopoulos, R Ardau, C Baethge, R Bauer, B Baune, F Bellivier, R Belmaker, M Berk, T Bjella, L Bossini, Y Bersudsky, E Wo Cheung, J Conell, M Del Zompo, S Dodd, B Etain, A Fagiolini, M Frye, K Fountoulakis, J Garneau-Fournier, A Gonzalez-Pinto, J Gottlieb, H Harima, S Hassel, C Henry, A Iacovides, E Isometsä, F Kapczinski, S Kliwicki, B König, R Krogh, M Kunz, B Lafer, E Larsen, U Lewitzka, C Lopez-Jaramillo, G MacQueen, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, S Monteith, G Morken, R Munoz, F Nery, C O'Donovan, Y Osher, A Pfennig, D Quiroz, R Ramesar, N Rasgon, A Reif, P Ritter, J Rybakowski, K Sagduyu, Â Miranda-Scippa, E Severus, C Simhandl, D Stein, S Strejilevich, A Sulaiman, K Suominen, H Tagata, Y Tatebayashi, C Torrent, E Vieta, B Viswanath, M Wanchoo, M Zetin, P Whybrow

(2015), Vol. 64, pp. 1-8, Journal of psychiatric research, Amsterdam, The Netherlands, C1

Tobacco use in bipolar disorder.

D Thomson, M Berk, S Dodd, M Rapado-Castro, S Quirk, P Ellegaard, L Berk, O Dean

(2015), Vol. 13, pp. 1-11, Clinical Psychopharmacology and Neuroscience, Korea (South), C1

Prevalence of cardiovascular and metabolic events in patients prescribed clozapine: a retrospective observational, clinical cohort study

N Hyde, S Dodd, K Venugopal, Purdie, M Berk, A O'Neil

(2015), Vol. 10, pp. 125-131, Current drug safety, San Francisco, Calif., C1

Nocebo effects in the treatment of major depression: results from an individual study participant-level meta-analysis of the placebo arm of duloxetine clinical trials

S Dodd, A Schacht, K Kelin, H Dueñas, V Reed, L Williams, F Quirk, G Malhi, M Berk

(2015), Vol. 76, pp. 702-711, Journal of clinical psychology, Weinheim, Germany, C1

Impact of cannabis use on long-term remission in bipolar I and schizoaffective disorder

S Kim, S Dodd, L Berk, J Kulkarni, A de Castella, P Fitzgerald, J Kim, J Yoon, M Berk

(2015), Vol. 12, pp. 349-355, Psychiatry Investigation, Seoul, Korea (South), C1

Evaluating discussion board engagement in the MoodSwings online self-help program for bipolar disorder: protocol for an observational prospective cohort study

E Gliddon, S Lauder, L Berk, V Cosgrove, D Grimm, S Dodd, T Suppes, M Berk

(2015), Vol. 15, pp. 1-9, BMC psychiatry, London, Eng., C1

Future directions for pharmacotherapies for treatment-resistant bipolar disorder

S Dodd, B Simoes Fernandes, O Dean

(2015), Vol. 13, pp. 656-662, Current neuropharmacology, Bussum, The Netherlands, C1

Castelli risk indexes 1 and 2 are higher in major depression but other characteristics of the metabolic syndrome are not specific to mood disorders

H Vargas, S Vargas Nunes, D Barbosa, M Vargas, A Cestari, S Dodd, K Venugopal, M Maes, M Berk

(2014), Vol. 102, pp. 65-71, Life sciences, Amsterdam, The Netherlands, C1

The efficacy of adjunctive N-Acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial

M Berk, O Dean, S Cotton, S Jeavons, M Tanious, K Kohlmann, K Hewitt, K Moss, C Allwang, I Schapkaitz, J Robbins, H Cobb, F Ng, S Dodd, A Bush, G Malhi

(2014), Vol. 75, pp. 628-636, Journal of clinical psychiatry, Memphis, Tenn., C1

Lowered plasma paraoxonase (PON) 1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder

C Bortolasci, H Odebrecht Vargas, A Souza-Nogueira, D Barbosa, E Moreira, S Obedrecht Vargas Nunes, M Berk, S Dodd, M Maes

(2014), Vol. 159, pp. 23-30, Journal of affective disorders, Amsterdam, The Netherlands, C1

Relationship between sunlight and the age of onset of bipolar disorder: An international multisite study

M Bauer, T Glenn, M Alda, O Andreasssen, E Angelopoulos, R Ardua, C Baethge, R Bauer, F Belliver, R Belmaker, M Berk, T Bjella, L Bossini, Y Bersudsky, E Cheung, J Conell, M Del Zompo, S Dodd, B Etain, A Fagionlini, M Frye, K Fountoulaski, J Garneau-Fournier, A Gonzalez-Pinto, H Harima, S Hassel, C Henry, A Iacovides, E Isometsa, F Kapczinski, S Kliwicki, B Konig, R Krogh, M Kunz, B Lafer, E Larsen, U Lewitzka, C Lopez-Jaramillo, G MacQueen, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, S Monteith, G Morken, R Munoz, F Nery, C O'Donovan, Y Osher, A Pfennig, D Quiroz, R Ramesar, N Rasgon, A Reif, P Ritter, J Rybakowski, K Sagduyu, A Scippa, E Severus, C Simhandl, D Stein, S Strejilevich, A Sulaiman, K Suominen, H Tagata, Y Tatebayashi, C Torrent, E Vieta, B Viswanath, M Wanchoo, M Zetin, P Whybrow

(2014), Vol. 167, pp. 104-111, Journal of affective disorders, Amsterdam, The Netherlands, C1

Impact of comorbid anxiety disorders and obsessive-compulsive disorder on 24-month clinical outcomes of bipolar I disorder

S Kim, L Berk, J Kulkarni, S Dodd, A de Castella, P Fitzgerald, G Amminger, M Berk

(2014), Vol. 166, pp. 243-248, Journal of Affective Disorders, Amsterdam, The Netherlands, C1

Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression

O Dean, A Turner, G Malhi, C Ng, S Cotton, S Dodd, J Sarris, Y Samuni, M Tanious, N Dowling, A Waterdrinker, D Smith, M Berk

(2014), Vol. 0, pp. 1-10, Revista Brasileira de psiquiatria, Sao Paulo, Brazil, C1

Paraoxonase 1 status and interactions between Q192R functional genotypes by smoking contribute significantly to total plasma radical trapping antioxidant potential.

C Bortolasci, M Maes, H Vargas, A Souza-Nogueira, E Moreira, S Nunes, M Berk, S Dodd, D Barbosa

(2014), Vol. 581, pp. 46-51, Neuroscience letters, Shannon, Ireland, C1

Application of the gradient boosted method in randomised clinical trials: participant variables that contribute to depression treatment efficacy of duloxetine, SSRIs or placebo

S Dodd, M Berk, K Kelin, Q Zhang, E Eriksson, W Deberdt, J Craig Nelson

(2014), Vol. 168, pp. 284-293, Journal of affective disorders, Amsterdam, The Netherlands, C1

Pop, heavy metal and the blues: secondary analysis of persistent organic pollutants (POP), heavy metals and depressive symptoms in the NHANES National Epidemiological Survey

M Berk, L Williams, A Andreazza, J Pasco, S Dodd, F Jacka, S Moylan, E Reiner, P Magalhaes

(2014), Vol. 4, pp. 1-9, BMJ Open, London, England, C1

Data Integration Protocol In Ten-steps (DIPIT) : a new standard for medical researchers

J Dipnall, M Berk, F Jacka, L Williams, S Dodd, J Pasco

(2014), Vol. 69, pp. 237-246, Methods, Amsterdam, The Netherlands, C1

SLC6A4 STin2 VNTR genetic polymorphism is associated with tobacco use disorder, but not with successful smoking cessation or smoking characteristics: a case control study

M Pizzo de Castro, M Maes, R Guembarovski, C Ariza, E Reiche, H Vargas, M Vargas, L de Melo, S Dodd, M Berk, M Watanabe, S Nunes

(2014), Vol. 15, pp. 1-9, BMC Genetics, London, England, C1

Quality of life in bipolar and schizoaffective disorder - a naturalistic approach.

M Martin-Subero, L Berk, S Dodd, V Kamalesh, M Maes, J Kulkarni, A De Castella, P Fitzgerald, M Berk

(2014), Vol. 55, pp. 1540-1545, Comprehensive Psychiatry, Malden, Mass., C1

Genetic polymorphisms in glutathione-S-transferases are associated with anxiety and mood disorders in nicotine dependence

S Odebrecht Vargas Nunes, M Pizzo de Castro, M Ehara Watanabe, R Losi Guembarovski, H Odebrecht Vargas, E Reiche, H Kaminami Morimoto, S Dodd, M Berk

(2014), Vol. 24, pp. 87-93, Psychiatric genetics, Philadelphia, PA, C1

Stage managing bipolar disorder.

M Berk, L Berk, S Dodd, S Cotton, C Macneil, R Daglas, P Conus, A Bechdolf, S Moylan, G Malhi

(2014), Vol. 16, pp. 471-477, Bipolar Disorders, Malden, Mass., C1

Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity

C Bortolasci, H Vargas, A Souza-Nogueira, E Gastaldello Moreira, S Vargas Nunes, M Berk, S Dodd, D Barbosa, M Maes

(2014), Vol. 19, pp. 232-241, Redox report, Leeds, England, C1

Association of paraoxonase (PON)1 activity, glutathione S-transferase GST T1/M1 and STin.2 polymorphisms with comorbidity of tobacco use disorder and mood disorders.

S Vargas Nunes, M Pizzo de Castro, E Moreira, R Guembarovski, D Barbosa, H Vargas, L Piccoli de Melo, C Bortolasci, M Watanabe, S Dodd, M Berk, M Maes

(2014), Vol. 585C, pp. 132-137, Neuroscience letters, Shannon, Ireland, C1

The association between dietary patterns, diabetes and depression.

J Dipnall, J Pasco, D Meyer, M Berk, L Williams, S Dodd, F Jacka

(2014), Vol. 174, pp. 215-224, Journal of Affective Disorders, Amsterdam, The Netherlands, C1

Development of an online intervention for bipolar disorder. www.moodswings.net.au

S Lauder, A Chester, D Castle, S Dodd, L Berk, B Klein, D Austin, M Gilbert, J Chamberlain, G Murray, C White, L Piterman, M Berk

(2013), Vol. 18, pp. 155-165, Psychology, health and medicine, Oxon, England, C1

The sick role, illness cognitions and outcomes in bipolar disorder

M Berk, L Berk, S Dodd, P Fitzgerald, A de Castella, S Filia, K Filia, A Brnabic, K Kelin, W Montgomery, J Kulkarni, L Stafford

(2013), Vol. 146, pp. 146-149, Journal of affective disorders, Amsterdam, Netherlands, C1

Clinical characteristics and smoking cessation : an analysis of sex and depressive disorders differences

S Nunes, M de Castro, H Vargasa, M Vargas, I de Batista Fonseca, S Dodd, M Berk

(2013), Vol. 12, pp. 158-165, Addictive disorders & their treatment, Philadelphia, PA, C1

Lamotrigine in epilepsy, pregnancy and psychiatry - a drug for all seasons?

F Vajda, S Dodd, D Horgan

(2013), Vol. 20, pp. 13-16, Journal of clinical neuroscience, Kidlington, England, C1

Putative neuroprotective agents in neuropsychiatric disorders

S Dodd, M Maes, G Anderson, O Dean, S Moylan, M Berk

(2013), Vol. 42, pp. 135-145, Progress in neuro-psychopharmacology and biological psychiatry, United States, C1

Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function

J Hodge, Y Wang, M Berk, F Collier, T Fernandes, M Constable, J Pasco, S Dodd, G Nicholson, R Kennedy, L Williams

(2013), Vol. 74, pp. 32-39, Biological psychiatry, Amsterdam, The Netherlands, C1

Metabolite profiles in the anterior cingulate cortex of depressed patients differentiate those taking N-acetyl-cysteine versus placebo

P Das, M Tanious, K Fritz, S Dodd, O Dean, M Berk, G Malhi

(2013), Vol. 47, pp. 347-354, Australian and New Zealand journal of psychiatry, London, England, C1

Biomarkers in bipolar disorder : a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force

B Frey, A Andreazza, J Houenou, S Jamain, B Goldstein, M Frye, M Leboyer, M Berk, G Malhi, C Lopez-Jaramillo, V Taylor, S Dodd, S Frangou, G Hall, B Fernandes, M Kauer-Sant'Anna, L Yatham, F Kapczinski, L Young

(2013), Vol. 47, pp. 321-332, Australian and New Zealand journal of psychiatry, London, England, C1-1

Oxidative stress and inflammatory markers are associated with depression and nicotine dependence

H Vargas, S Nunes, M de Castro, M Vargas, D Barbosa, C Bortolasci, K Venugopal, S Dodd, M Berk

(2013), Vol. 544, pp. 136-140, Neuroscience letters, Amsterdam, The Netherlands, C1

Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts

H Vargas, S Vargas Nunes, M de Castro, C Bortolasci, D Barbosa, H Morimoto, K Venugopal, S Dodd, M Maes, M Berk

(2013), Vol. 150, pp. 923-930, Journal of affective disorders, Amsterdam, The Netherlands, C1

Treatment response for acute depression is not associated with number of previous episodes: lack of evidence for a clinical staging model for major depressive disorder

S Dodd, M Berk, K Kelin, M Mancini, A Schacht

(2013), Vol. 150, pp. 344-349, Journal of affective disorders, Amsterdam, The Netherlands, C1

The shared role of oxidative stress and inflammation in major depressive disorder and nicotine dependence

S Nunes, H Vargas, E Prado, D Barbosa, L Picoli de Melo, S Moylan, S Dodd, M Berk

(2013), Vol. 37, pp. 1336-1345, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

Hyponatraemia: an audit of aged psychiatry patients taking SSRIs and SNRIs

F Giorlando, J Teister, S Dodd, M Udina, M Berk

(2013), Vol. 8, pp. 175-180, Current drug safety, Bussum, The Netherlands, C1

Evaluation of the acceptability and usefulness of an information website for caregivers of people with bipolar disorder

L Berk, M Berk, S Dodd, C Kelly, S Cvetkovski, A Jorm

(2013), Vol. 11, pp. 1-13, BMC medicine, London, Eng., C1-1

To a broader concept of remission: rating the health-related quality of life in bipolar disorder

M Subero, L Berk, S Dodd, J Kulkarni, A De Castella, P Fitzgerald, M Berk

(2013), Vol. 150, pp. 673-676, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

Psychometric properties of a scale to measure investment in the sick role : the Illness Cognitions Scale

M Berk, L Berk, S Dodd, F Jacka, P Fitzgerald, A de Castella, S Filia, K Filia, J Kulkarni, H Jackson, L Stafford

(2012), Vol. 18, pp. 360-364, Journal of evaluation of clinical practice, Oxford, England, C1-1

A comparison of inflammatory markers in depressed and nondepressed smokers.

S Nunes, H Vargas, J Brum, E Prado, M Vargas, M de Castro, S Dodd, M Berk

(2012), Vol. 14, pp. 540-546, Nicotine and tobacco research, Oxford , England, C1-1

Impact of sunlight on the age of onset of bipolar disorder

M Bauer, T Glenn, M Alda, O Andreassen, R Ardau, F Bellivier, M Berk, T Bjella, L Bossini, M Del Zompo, S Dodd, A Fagiolini, M Frye, A Gonzalex-Pinto, C Henry, F Kapczinski, S Kliwicki, B Konig, M Kunz, B Lafer, C Lopez-Jaramillo, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, R Morken, R Munoz, C O'Donovan, F Nery, A Pfennig, D Quiroz, N Rasgon, A Reif, J Rybakowski, K Sagduyu, C Simhandi, C Torrent, E Vieta, M Zetin, P Whybrow

(2012), Vol. [early view], pp. 1-10, Bipolar disorders, Malden, Mass., C1

Pain and the relationship with mood and anxiety disorders and psychological symptoms

L Williams, J Pasco, F Jacka, S Dodd, M Berk

(2012), Vol. 72, pp. 452-456, Journal of psychosomatic research, Philadelphia, Pa., C1

Illness burden and medical comorbidity in the systematic treatment enhancement program for bipolar disorder

P Magalhaes, F Kapczinski, A Nierenberg, T Deckersbach, D Weisinger, S Dodd, M Berk

(2012), Vol. 125, pp. 303-308, Acta psychiatrica scandinavica, Malden, Mass., C1

Maintenance N-acetyl cysteine treatment for bipolar disorder : a double-blind randomised placebo controlled trial

M Berk, O Dean, S Cotton, C Gama, F Kapczinski, B Fernandes, K Kohlmann, S Jeavons, K Hewitt, K Moss, C Allwang, I Schapkaitz, H Cobb, A Bush, S Dodd, G Malhi

(2012), Vol. 10, pp. 1-11, BMC medicine, London, England, C1

Treatment and outcomes of an Australian cohort of outpatients with bipolar 1 or schizoaffective disorder over twenty-four months : implications for clinical practice

J Kulkarni, S Filia, L Berk, K Filia, S Dodd, A de Castella, A Brnabic, A Lowry, K Kelin, W Montgomery, P Fitzgerald, M Berk

(2012), Vol. 12, pp. 1-11, BMC psychiatry, London, England, C1

Cumulative morbidity and prognostic staging of illness in the systematic treatment enhancement program for Bipolar Disorder (STEP-BD)

P Magalhaes, S Dodd, A Nierenberg, M Berk

(2012), Vol. 46, pp. 1058-1067, Australian and New Zealand journal of psychiatry, London, England, C1

Lower levels of physical activity in childhood associated with adult depression

F Jacka, J Pasco, L Williams, E Leslie, S Dodd, G Nicholson, M Kotowicz, M Berk

(2011), Vol. 14, pp. 222-226, Journal of science and medicine in sport, Chatswood, N.S.W., C1

Annual high-dose vitamin D3 and mental well-being: randomised controlled trial

K Sanders, A Stuart, E Wiliamson, F Jacka, S Dodd, G Nicholson, M Berk

(2011), Vol. 198, pp. 357-364, British journal of psychiatry, London, England, C1-1

Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention

M Berk, A Brnabic, S Dodd, K Kelin, M Tohen, G Malhi, L Berk, P Conus, P McGorry

(2011), Vol. 13, pp. 87-98, Bipolar disorders, Malden, Mass, C1

Pathways underlying neuroprogression in bipolar disorder : focus on inflammation, oxidative stress and neurotrophic factors

M Berk, F Kapczinski, A Andreazza, O Dean, F Giorlando, M Maes, M Yücel, C Gama, S Dodd, B Dean, P Magalhães, P Amminger, P McGorry, G Malhi

(2011), Vol. 35, pp. 804-817, Neuroscience & biobehavioral reviews, Oxford, England, C1-1

Combination antidepressants : use by GPs and psychiatrists

D Horgan, S Dodd

(2011), Vol. 40, pp. 397-400, Australian family physician, Sydney, N.S.W., C1-1

The relationship between substance use and post-traumatic stress disorder in a methadone maintenance treatment program

K Villagonzalo, S Dodd, F Ng, S Mihaly, A Langbein, M Berk

(2011), Vol. 52, pp. 562-566, Comprehensive psychiatry, Maryland Heights, MO, C1-1

Bipolar disorder and adiposity : a study using whole body dual energy X-ray absorptiometry scans

L Williams, J Pasco, F Jacka, M Henry, S Dodd, G Nicholson, M Kotowicz, M Berk

(2011), Vol. 23, pp. 219-223, Acta neuropsychiatrica, Malden, Mass, C1

The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression : an open label trial

M Berk, O Dean, S Cotton, C Gama, F Kapczinski, B Fernandes, K Kohlmann, S Jeavons, K Hewitt, C Allwang, H Cobb, A Bush, I Schapkaitz, S Dodd, G Malhi

(2011), Vol. 135, pp. 389-394, Journal of affective disorders, Amsterdam, Netherlands, C1

A consensus statement for safety monitoring guidelines of treatments for major depressive disorder

S Dodd, G Malhi, J Tiller, I Schweitzer, I Hickie, J Khoo, D Bassett, B Lyndon, P Mitchell, G Parker, P Fitzgerald, M Udina, A Singh, S Moylan, F Giorlando, C Doughty, C Davey, M Theodoros, M Berk

(2011), Vol. 45, pp. 712-725, Australian and New Zealand journal of psychiatry, London, England, C1

Development of guidelines for caregivers of people with bipolar disorder : a Delphi expert consensus study

L Berk, A Jorm, C Kelly, S Dodd, M Berk

(2011), Vol. 13, pp. 556-570, Bipolar disorders, Malden Mass., C1

Mental health services for young people - the challenge of integrating services

T Callaly, K Von Treuer, S Dodd, M Berk

(2010), Vol. 22, pp. 158-160, Acta neuropsychiatrica, Oxford, England, C1

Readmission to an acute psychiatric unit within 28 days of discharge : identifying those at risk

T Callaly, M Hyland, T Trauer, S Dodd, M Berk

(2010), Vol. 34, pp. 282-285, Australian health review, Melbourne, Vic., C1

A naturalistic study of treatment outcomes with aripiprazole in young people with first episode psychosis

S Dodd, T Callaly, A Thampi, S McConnell, P Hantz, D Goodman, K Kohlmann, P Vieira da Silva Magalhaes, M Berk

(2010), Vol. 8, pp. 105-110, Clinical psychopharmacology and neuroscience, Seoul, Korea, C1

Obesity is associated with previous suicide attempts in bipolar disorder

F Gomes, M Kauer-Sant'Anna, P Magalhães, F Jacka, S Dodd, C Gama, Â Cunha, M Berk, F Kaczinski

(2010), Vol. 22, pp. 63-67, Acta neuropsychiatrica, Oxford, England, C1-1

The prevalence of mood and anxiety disorders in Australian women

L Williams, F Jacka, J Pasco, M Henry, S Dodd, G Nicholson, M Kotowicz, M Berk

(2010), Vol. 18, pp. 250-255, Australasian psychiatry, London, England, C1-1

Oxidative pathways as a drug target for the treatment of autism

K Villagonzalo, S Dodd, O Dean, K Gray, B Tonge, M Berk

(2010), Vol. 14, pp. 1301-1310, Expert opinion on therapeutic targets, London, England, C1-1

Restless leg syndrome caused by olanzapine: a case series

S Aggarwal, S Dodd, M Berk

(2010), Vol. 5, pp. 129-131, Current drug safety, San Francisco, Ca., C1-1

From neuroprogression to neuroprotection : implications for clinical care

M Berk, P Conus, F Kapczinski, A Andreazza, M Yücel, S Wood, C Pantelis, G Malhi, S Dodd, A Bechdolf, G Amminger, I Hickie, P McGorry

(2010), Vol. 193, pp. 36-40, Medical journal of australia, Strawberry Hills, N.S.W., C1-1

The validity and internal structure of the bipolar depression rating scale (BDRS): data from a clinical trial of N-acetylcysteine as adjunctive therapy in bipolar disorder

M Berk, S Dodd, O Dean, K Kohlmann, L Berk, G Malhi

(2010), Vol. 22, pp. 237-242, Acta neuropsychiatrica, Oxford, England, C1-1

Evidence and implications for early intervention in bipolar disorder

M Berk, K Hallam, G Mahli, L Henry, M Hasty, C Macneil, M Yucel, C Pantelis, B Murphy, E Vieta, S Dodd, P McGorry

(2010), Vol. 19, pp. 113-126, Journal of mental health, Abingdon, England, C1-1

Do we need to flick the switch? The need for a broader conceptualization of iatrogenic course aggravation in clinical trials of bipolar disorder?

M Berk, F Ng, S Dodd, J Goldberg, G Malhi

(2010), Vol. 64, pp. 367-371, Psychiatry and clinical neurosciences, Richmond, Vic., C1-1

A qualitative evaluation of a regional early psychosis service 3 years after its commencement

T Callaly, C Ackerly, M Hyland, S Dodd, M O'Shea, M Berk

(2010), Vol. 34, pp. 382-385, Australian health review, Melbourne, Vic., C1-1

A prospective study of the impact of smoking on outcomes in bipolar and schizoaffective disorder

S Dodd, A Brnabic, L Berk, P Fitzgerald, A de Castella, S Filia, K Filia, K Kelin, M Smith, W Montgomery, J Kulkarni, M Berk

(2010), Vol. 51, pp. 504-509, Comprehensive psychiatry, Maryland Heights, MO, C1-1

A prospective study of the impact of subthreshold mixed states on the 24-month clinical outcomes of bipolar I disorder or schizoaffective disorder

S Dodd, J Kulkarni, L Berk, F Ng, P Fitzgerald, A de Castella, S Filia, K Filia, W Montgomery, K Kelin, M Smith, A Brnabic, M Berk

(2010), Vol. 124, pp. 22-28, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia

J Kulkarni, C Gurvich, S Lee, H Gilbert, E Gavrilidis, A de Castella, M Berk, S Dodd, P Fitzgerald, S Davis

(2010), Vol. 35, pp. 1142-1147, Psychoneuroendocrinology, Oxford, England, C1-1

The role of psychotherapy in bipolar disorder

S Lauder, M Berk, D Castle, S Dodd, L Berk

(2010), Vol. 193, pp. 31-35, Medical journal of australia, Sydney, N.S.W., C1-1

The utility of the Mood Disorders Questionnaire as a screening tool in a methadone maintenance treatment program

K Villagonzalo, S Dodd, F Ng, S Mihaly, A Langbein, M Berk

(2010), Vol. 14, pp. 150-153, International journal of psychiatry in clinical practice, London, England, C1-1

Description and qualitative evaluation of Jigsaw, an integrated young persons' mental health program

T Callaly, S Dodd, C Ackerly, P Hantz, M O'Shea, M Berk

(2009), Vol. 17, pp. 480-483, Australasian Psychiatry, London, England, C1-1

Suicidality - the challenge for public mental health services

T Callaly, M Berk, S Dodd

(2009), Vol. 21, pp. 41-43, Acta neuropsychiatrica, Oxford, England, C1-1

Vitamin D: is it relevant to psychiatry?

M Berk, S Dodd, L Williams, F Jacka, J Pasco

(2009), Vol. 21, pp. 205-206, Acta neuropsychiatrica, Oxford, England, C1-1

Reliability of the mood disorder questionnaire : comparison with the structured clinical interview for the DSM-IV-TR in a population sample

S Dodd, L Williams, F Jacka, J Pasco, O Bjerkeset, M Berk

(2009), Vol. 43, pp. 526-530, Australian and New Zealand journal of psychiatry, Melbourne, Vic., C1-1

Depression and bone metabolism : a review

L Williams, J Pasco, F Jacka, M Henry, S Dodd, M Berk

(2009), Vol. 78, pp. 16-25, Psychotherapy and psychosomatics, New York, N. Y., C1-1

Lifetime psychiatric disorders and body composition : a population-based study

L Williams, J Pasco, M Henry, F Jacka, S Dodd, G Nicholson, M Kotowicz, M Berk

(2009), Vol. 118, pp. 173-179, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

Nail-biting stuff? The effect of N-acetyl cysteine on nail-biting

M Berk, S Jeavons, O Dean, S Dodd, K Moss, C Gama, G Malhi

(2009), Vol. 14, pp. 357-360, CNS spectrums, New York, N.Y., C1-1

A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice.

O Dean, M van den Buuse, A Bush, D Copolov, F Ng, S Dodd, M Berk

(2009), Vol. 16, pp. 2965-2976, Current medicinal chemistry, Schiphol, The Netherlands, C1-1

Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics : a double-blind, randomised, placebo-controlled clinical trial

M Berk, C Gama, S Sundram, H Hustig, L Koopowitz, R D'Souza, H Malloy, C Rowland, A Monkhouse, A Monkhouse, F Bole, S Sathiyamoorthy, D Piskulic, S Dodd

(2009), Vol. 24, pp. 233-238, Human psychopharmacology : clinical and experimental, West Sussex, England, C1-1

Early intervention in bipolar disorders : clinical, biochemical and neuroimaging imperatives

M Berk, G Malhi, K Hallam, C Gama, S Dodd, A Andreazza, B Frey, F Kapczinski

(2009), Vol. 114, pp. 1-13, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

Effects of N-acetylcysteine on substance use in bipolar disorder : a randomized placebo controlled clinical trial

M Bernardo, S Dodd, C Gama, D Copolov, O Dean, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, A Bush, M Berk

(2009), Vol. 21, pp. 239-245, Acta neuropsychiatrica, Oxford, England, C1-1

The impact of age at onset of bipolar I disorder on functioning and clinical presentation

F Biffin, S Tahtalian, K Filia, P Fitzgerald, A De Castella, S Filia, M Berk, S Dodd, P Callaly, L Berk, K Kelin, M Smith, W Montgomery, J Kulkarni

(2009), Vol. 21, pp. 191-196, Acta neuropsychiatrica, Oxford, England, C1-1

Client-reported reasons for non-engagement in drug and alcohol treatment

C Coulson, F Ng, M Geertsema, S Dodd, M Berk

(2009), Vol. 28, pp. 372-378, Drug and alcohol review, Oxford, England, C1-1

Development of guidelines for carers of adults with bipolar disorder

S Dodd, L Berk, C Kelly, A Jorm

(2009), Vol. 11, pp. 785-785, Bipolar disorders, Malden, MA, C1-1

'Mind and body' : a lifestyle programme for people on antipsychotic medication

A Jones, A Benson, S Griffiths, M Berk, S Dodd

(2009), Vol. 15, pp. 276-280, Journal of evaluation of clinical practice, Oxford, England, C1-1

Improvement of negative and positive symptoms in treatment-refractory schizophrenia : a double-blind, randomized, placebo-controlled trial with memantine as add-On therapy to clozapine

D De Lucena, B Fernandes, M Berk, S Dodd, D Medeiros, M Pedrini, M Kunz, F Gomes, L Giglio, M Lobato, P Belmonte-de-Abreu, C Gama

(2009), Vol. 70, pp. 1416-1423, Journal of clinical psychiatry, Memphis, Tenn., C1-1

The management of individuals with bipolar disorder : a review of the evidence and its integration into clinical practice

G Malhi, D Adams, C Cahill, S Dodd, M Berk

(2009), Vol. 69, pp. 2063-2101, Drugs, London, England, C1-1

A descriptive interview with 64 patients discharged from an acute-psyciatric-inpatient service

T Callaly, S Dodd, D Goodman, Y Asgari, M Berk

(2008), Vol. 14, pp. 990-995, Journal of evaluation in clinical practice, Oxford, England, C1-1

Is this D vitamin to worry about? Vitamin D insufficiency in an inpatient sample

M Berk, F Jacka, L Williams, F Ng, S Dodd, J Pasco

(2008), Vol. 42, pp. 874-878, Australian and New Zealand journal of psychiatry, Abingdon, England, C1-1

Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression

L Williams, M Henry, M Berk, S Dodd, F Jacka, M Kotowicz, G Nicholson, J Pasco

(2008), Vol. 23, pp. 84-87, International clinical psychopharmacology, Philadelphia, Pa., C1-1

Glutathione : a novel treatment target in psychiatry

M Berk, F Ng, O Dean, S Dodd, A Bush

(2008), Vol. 29, pp. 346-351, Trends in pharmacological sciences, London, England, C1-1

N-acetylcysteine for antioxidant therapy : pharmacology and clinical utility

S Dodd, O Dean, D Copolov, G Malhi, M Berk

(2008), Vol. 8, pp. 1955-1962, Expert opinion on biological therapy, London, England, C1-1

Small shifts in diurnal rhythms are associated with an increase in suicide : the effect of daylight saving

M Berk, S Dodd, K Hallam, L Berk, J Gleeson, M Henry

(2008), Vol. 6, pp. 22-25, Sleep and biological rhythms, Wiley-Blackwell Publishing Asia, C1-1

The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical use

M Berk, F Ng, S Dodd, T Callaly, S Campbell, M Bernardo, T Trauer

(2008), Vol. 14, pp. 979-983, Journal of evaluation of clinical practice, Oxford, England, C1-1

Going up in smoke : tobacco smoking is associated with worse treatment outcomes in mania

M Berk, F Ng, W Wang, M Tohen, D Lubman, E Vieta, S Dodd

(2008), Vol. 110, pp. 126-134, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

Olanzapine / fluoxetine combination for treatment resistant depression : efficacy and clinical utility

S Dodd, M Berk

(2008), Vol. 8, pp. 1299-1306, Expert review of neurotherapeutics, London, England, C1-1

Duloxetine for major depression

S Dodd, M Berk

(2008), Vol. 9, pp. 65-66, Medicine today, Neutral Bay, N.S.W., C1-1

The bipolar comprehensive outcomes study (BCOS) : baseline findings of an Australian cohort study

J Kulkarni, M Berk, P Fitzgerald, A de Castella, W Montgomery, K Kelin, A Brnabic, R Granger, S Dodd

(2008), Vol. 107, pp. 135-144, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

Depressive disorders and bone mineral density in a community based sample of premenopausal women

L Williams, J Pasco, F Jacka, S Dodd, G Nicholson, M Berk

(2008), Vol. 107, pp. 96-97, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

Effects of a walking program in the psychiatric in-patient treatment setting: a cohort study.

F Ng, S Dodd, F Jacka, E Leslie, M Berk

(2007), Vol. 18, pp. 39-42, Health promotion journal of Australia, West Perth, W.A., C1

Vitamin D deficiency may play a role in depression

M Berk, K Sanders, J Pasco, F Jacka, L Williams, A Hayles, S Dodd

(2007), Vol. 69, pp. 1316-1319, Medical hypotheses, Amsterdam, The Netherlands, C1-1

Setting the stage : from prodrome to treatment resistance in bipolar disorder

M Berk, P Conus, N Lucas, K Hallam, G Malhi, S Dodd, L Yatham, A Yung, P McGorry

(2007), Vol. 9, pp. 671-678, Bipolar disorders, Copenhagen, Denmark, C1-1

History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorder

M Berk, S Dodd, P Callaly, L Berk, P Fitzgerald, A de Castella, S Filia, K Filia, S Tahtalian, F Biffin, K Kelin, M Smith, W Montgomery, J Kulkarni

(2007), Vol. 103, pp. 181-186, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

Dopamine dysregulation syndrome : implications for a dopamine hypothesis of bipolar disorder

M Berk, S Dodd, M Kauer-Sant'Anna, G Malhi, M Bourin, F Kapczinski, T Norman

(2007), Vol. 116, pp. 41-49, Acta Psychiatrica Scandinavica, Hoboken, N.J., C1-1

Monitoring the safe use of Clozapine : a consensus view from Victoria, Australia

M Berk, J Fitzsimons, T Lambert, C Pantelis, J Kulkarni, D Castle, E Ryan, S Jespersen, P McGorry, G Berger, B Kuluris, T Callaly, S Dodd

(2007), Vol. 21, pp. 117-127, CNS drugs, London, England, C1-1

A survey of combination antidepressant use in Australia

D Horgan, S Dodd, M Berk

(2007), Vol. 15, pp. 26-29, Australasian psychiatry, London, England, C1-1

Atypical antipsychotics for bipolar disorder : overblown or blown over?

F Ng, S Dodd, M Berk

(2007), Vol. 5, pp. 53-64, Clinical psychopharmacology and neuroscience, Seoul, Korea, C1-1

The effects of physical activity in the acute treatment of bipolar disorder : a pilot study

F Ng, S Dodd, M Berk

(2007), Vol. 101, pp. 259-262, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

The benefits of physical activity in the management of bipolar disorder

F Ng, S Dodd, M Berk

(2007), Vol. 9, pp. 83-83, Bipolar disorders, Copenhagen, Denmark, C1-1

The validity of the 21-item version of the depression anxiety stress scales as a routine outcome measure

F Ng, T Trauer, S Dodd, T Callaly, S Campbell, M Berk

(2007), Vol. 19, pp. 304-310, Acta neuropsychiatrica, Oxford, England, C1-1

Depression and pain : an overview

L Williams, F Jacka, J Pasco, S Dodd, M Berk

(2006), Vol. 18, pp. 79-87, Acta neuropsychiatrica, Oxford, England, C1-1

Diagnosing bipolar disorder : how can we do it better?

M Berk, L Berk, S Dodd, K Moss, G Malhi

(2006), Vol. 184, pp. 459-462, Medical journal of Australia, Strawberry Hills, N. S. W., C1-1

Do magnetic fields affect behaviour? A demonstration of the relationship between geomagnetic storm activity and suicide

M Berk, S Dodd, M Henry

(2006), Vol. 27, pp. 151-155, Bioelectromagnetics, New York, N.Y., C1-1

It's the economy : the effect of macroeconomic variables of the rate of suicide

M Berk, S Dodd, M Henry

(2006), Vol. 36, pp. 181-189, Psychological medicine, Cambridge, England, C1-1

Health-related quality of life and functioning in bipolar disorder : the impact of pharmacotherapy

M Berk, K Hallam, N Lucas, L Kader, C MacNeil, M Hasty, S Dodd, G Malhi, P Conus

(2006), Vol. 6, pp. 509-523, Expert review of pharmacoeconomics and outcomes research, London, England, C1-1

The safety of medications for the treatment of bipolar disorder during pregnancy and the peurperium

S Dodd, M Berk

(2006), Vol. 1, pp. 25-33, Current drug safety, Bussum, The Netherlands, C1-1

Combination pharmacotherapy in unipolar depression

F Ng, S Dodd, M Berk

(2006), Vol. 6, pp. 1049-1060, Expert review of neurotherapeutics, London, England, C1-1

Depression and bone mineral density in a community sample of perimenopausal women: Geelong Osteoporosis Study

F Jacka, J Pasco, M Henry, M Kotowicz, S Dodd, G Nicholson, M Berk

(2005), Vol. 12, pp. 88-91, Menopause, New York, N. Y., C1-1

The relationship between depression and cardiovascular disease

S McConnell, F Jacka, L Williams, S Dodd, M Berk

(2005), Vol. 9, pp. 157-167, International journal of psychiatry in clinical practice, London, England, C1-1

Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression?

M Berk, S Dodd

(2005), Vol. 65, pp. 39-43, Medical hypotheses, Amsterdam , Netherlands, C1-1

Bipolar II disorder : a review

M Berk, S Dodd

(2005), Vol. 7, pp. 11-21, Bipolar disorders, Malden, Mass, C1-1

Efficacy of atypical antipsychotics in bipolar disorder

M Berk, S Dodd

(2005), Vol. 65, pp. 257-269, Drugs, Auckland, New Zealand, C1-1

The management of bipolar disorder in primary care : a review of existing and emerging therapies

M Berk, S Dodd, L Berk

(2005), Vol. 59, pp. 229-239, Psychiatry and clinical neurosciences, Richmond, Vic., C1-1

Diagnosis and management of patients with bipolar disorder in primary care

M Berk, S Dodd, L Berk, J Opie

(2005), Vol. 55, pp. 662-664, British journal of general practice, London, Eng., C1-1

Bipolar missed states : the diagnosis and clinical salience of bipolar mixed states

M Berk, S Dodd, G Mahli

(2005), Vol. 39, pp. 215-221, Australian and New Zealand journal of psychiatry, Abingdon, England, C1-1

To combine or not to combine? A literature review of antidepressant combination therapy

S Dodd, D Horgan, G Mahli, M Berk

(2005), Vol. 89, pp. 1-3, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

Clinical characteristics and management of bipolar disorder in women across the life span

S Dodd, S Katsenos, J Tiller, M Berk

(2005), Vol. 1, pp. 421-428, Women's health, London, England, C1-1

A review of clozapine safety

J Fitzsimons, M Berk, T Lambert, M Bourin, S Dodd

(2005), Vol. 4, pp. 731-744, Expert opinion on drug safety, London, England, C1-1

Atypical mood stabilizers : a 'typical' role for atypical antipsychotics

G Malhi, M Berk, M Bourin, B Ivanovski, S Dodd, J Lagopoulos, P Mitchell

(2005), Vol. 111, pp. 29-38, Acta psychiatrica Scandinavica, Malden, Ma., C1-1

The pharmacology of bipolar disorder during pregnancy and breastfeeding

S Dodd, M Berk

(2004), Vol. 3, pp. 221-229, Expert opinion on drug safety, London, England, C1-1

Predictors of antidepressant response : a selective review

S Dodd, M Berk

(2004), Vol. 8, pp. 91-100, International journal of psychiatry in clinical practice, London, England, C1-1

A pilot randomized, double-blind, placebo-controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use

S Jespersen, M Berk, C Van Wyk, O Dean, S Dodd, C Szabo, C Maud

(2004), Vol. 19, pp. 161-164, International clinical psychopharmacology, Philadelphia, Pa., C1-1

An audit of clinical outcomes and client and referrer satisfaction with a mood and anxiety Disorders unit

R Lewis, E Musella, M Berk, S Dodd, H McKenzie, M Hyland

(2004), Vol. 10, pp. 549-552, Journal of evaluation of clinical practice, Oxford, England, C1-1

One step purification of alpha-1-acid glycoprotein from human plasma : fractionation of its polymorphic allele products

F Azzimonti, D Atchley, C Morrison, S Dodd, D Boulton, C DeVane, P Arnaud

(2003), Vol. 784, pp. 33-38, Journal of chromatography. B, analytical technologies in the biomedical and life sciences, Amsterdam, The Netherlands, C1-1

Recent developments in the treatment of bipolar disorders

M Berk, S Dodd

(2003), Vol. 12, pp. 1621-1632, Expert opinion on investigational drugs, London, England, C1-1

Dietary levels of quinine in tonic water do not inhibit CYP2D6 in vivo

J Donovan, C DeVane, D Boulton, S Dodd, J Markowitz

(2003), Vol. 41, pp. 1199-1201, Food and chemical toxicology, Oxford, England, C1-1

Identification of a by-product of nitric oxide synthase activity in human acute brain injury with in vivo proton magnetic resonance spectroscopy

M Silberstein, D Lane, S Dodd, K Opeskin

(2002), Vol. 23, pp. 389-392, American journal of neuroradiology, [Oakbrook, Ill.], C1-1

In vitro metabolism of mirtazapine enatiomers by human cytochrome P450 enzymes

S Dodd, D Boulton, G Burrows, C DeVane, T Norman

(2001), Vol. 16, pp. 541-544, Human psychopharmacology clinical & experimental, West Sussex, England, C1-1

Antidepressants and breast-feeding : a review of the literature

S Dodd, A Buist, T Norman

(2000), Vol. 2, pp. 183-192, Paediatric drugs, Auckland, N.Z., C1-1

Chiral determination of mirtazapine in human blood plasma by high-performance liquid chromatography

S Dodd, G Burrows, T Norman

(2000), Vol. 748, pp. 439-443, Journal of chromatography b, Amsterdam, The Netherlands, C1-1

Sertraline in paired blood plasma and breast-milk samples from nursing mothers

S Dodd, A Stocky, A Buist, G Burrows, K Maguire, T Norman

(2000), Vol. 15, pp. 261-264, Human psychopharmacology clinical & experimental, West Sussex, England, C1-1

Determination of nefazodone and its pharmacologically active metabolites in human blood plasma and breast milk by high-performance liquid chromatography

S Dodd, A Buist, G Burrows, K Maguire, T Norman

(1999), Vol. 730, pp. 249-255, Journal of chromatography b, Amsterdam, The Netherlands, C1-1